Novavax has been in the pharmaceuticals business since 1987 but has yet to get a single vaccine past the U.S. Food and Drug Administration.
So far, the candidates currently in the running include a new type of vaccine seen as “risky,” and an old-fashioned type known to be only temporary.
Under the best of circumstances, Americans could be in for a long, messy immunization battle against the novel coronavirus—one lasting years or even decades.
Some involved the gene-editing technique known as CRISPR. One involves putting a specially engineered gold particle into the retina.
A new Harvard study, amplified by Trump, finds that months before China warned of an outbreak, there was a surge in traffic to Wuhan hospitals. But experts are not convinced.
TXA127, now used to treat strokes, won’t go on the attack against the virus. Instead, this drug, which will soon get its first clinical trial at Columbia, works on defense.
Children are much less likely to be infected, less likely to become severely ill, and less likely to spread infection. We should let our children return to their normal lives.